Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 55

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 55
---
 months from the date of issuance and will expire five years from
the initial exercise date.

Roth Capital Partners, LLC (the “February 2022
Placement Agent”) acted as the exclusive placement agent for the February 2022 Offerings, pursuant to a placement agency agreement
(the “February 2022 Placement Agreement”), dated February 21, 2022, by and between the Company and the February 2022
Placement Agent.

The closing of the February 2022 Offerings
took place on February 24, 2022. The February 2022 Common Warrants and shares of Common Stock issuable upon exercise thereof
were issued in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation
D promulgated thereunder for transactions not involving a public offering.

The net proceeds from the February 2022
Offerings were approximately $3.7 million. Net proceeds are what we received after paying the placement agent’s fees and other
expenses of the offering. The net proceeds exclude the proceeds, if any, from the exercise of the February 2022 Pre-Funded Warrants
and the February 2022 Common Warrants sold in the February 2022 Offerings.

Each of the above securities were not registered
under the Securities Act and were issued in reliance on the exemptions from registration provided by Section 4(a)(2) under
the Securities Act and Regulation D promulgated thereunder, for transactions not involving a public offering. The Company filed a registration
statement for the resale of the February 2022 Common Warrants on July 19, 2022, and the registration statement was declared
effective on July 27, 2022.

January 2024 Offering

On January 31,
2024, the Company entered into a Placement Agreement (the “January 2024 Placement Agreement”) with Maxim Group (“Maxim”)
pursuant to which Maxim agreed to serve as the sole placement agent, on a “reasonable best efforts” basis, in connection
with the an offering (the “January 2024 Offering”) of 3,228,056 shares of the Company’s Common Stock and
pre-funded warrants to purchase up to 2,416,005 shares of Common Stock, and in a concurrent private placement, unregistered common
warrants (the “January 2024 Common Warrants”) to purchase up to 41,640,625 shares of Common Stock. Also on January 31,